You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Kolon Life Science Secures Canadian Patent for Scalable Oncolytic Virus Manufacturing Process Kolon Life Science has obtained a Canadian patent allowance for its innovative large-scale production method of KLS-3021, an oncolytic virus candidate targeting solid tumors. This patent enhances the company’s intellect... Read the full IIPLA article: https://iipla.org/news/kolon-life-science-secures-canadian-patent-for-scalable-oncolytic-virus-manufacturing-process